Date: Oct 30, 2012 Author: Ira Kantor Source: Boston Herald (
click here to go to the source)
Thermedical, a privately held, Waltham-based medical equipment company, has received U.S. Food and Drug Administration clearance to market its technology for the ablation and coagulation of soft tissue during specific surgical procedures.
FDA clearance of the Thermedical Ablation System was based on substantial preclinical testing carried out under multiple grants from the National Institutes of Health, the company said, adding Thermedical was also awarded a $500,000 grant from the Massachusetts Life Sciences Center.
"Receiving FDA clearance is a significant milestone for Thermedical as it will facilitate our plans to carry out a series of clinical trials to evaluate the efficacy of our system for treating large, solid tumors, including liver cancer," said Thermedical president Michael Curley. "We are in active discussions with leading medical centers in the United States to begin these clinical trials, and we look forward to reporting our results in the future."
